QUINCE THERAPEUTICS INC (QNCX) Stock Balance Sheet
USA - NASDAQ:QNCX - US22053A1079 - Common Stock
1.56 USD
-0.03 (-1.89%)
1.5303 USD
-0.03 (-1.9%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 827.00K | 2.51M | 1.52M | 4.00M | 40.30M | |||
| Cash Equivalents | 16.00M | 3.70M | 4.29M | 11.00M | 16.00M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 17.88M | 34.57M | 69.25M | 75.20M | 50.60M | |||
| Receivables | 992.00K | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.65M | 3.25M | 2.38M | 3.60M | 4.90M | |||
| Total Current Assets | 37.34M | 44.04M | 77.44M | 93.70M | 111.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.08M | 813.00K | 619.00K | 700.00K | 1.40M | |||
| Investments And Advances | 78.00K | 78.00K | 78.00K | 3.60M | 19.90M | |||
| Goodwill | null | 0 | 17.63M | null | null | |||
| Intangibles | 67.57M | 60.05M | 63.67M | 5.90M | null | |||
| Other Non-Current Assets | null | 4.05M | 8.47M | 0 | 200.00K | |||
| Total Non-Current Assets | 79.86M | 70.44M | 90.46M | 10.20M | 21.50M | |||
| TOTAL ASSETS | 117.21M | 114.48M | 167.90M | 103.90M | 133.20M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | 0 | 100.00K | null | |||
| Accrued Expenses | 5.71M | 4.38M | 3.44M | 2.40M | 9.30M | |||
| Accounts Payable | 1.76M | 2.90M | 2.03M | 600.00K | 4.90M | |||
| Other Current Liabilities | null | 0 | 4.10M | null | null | |||
| Total Current Liabilities | 7.47M | 7.28M | 9.57M | 3.10M | 14.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 16.99M | 14.32M | 13.43M | 0 | 0 | |||
| Deferred Taxes/Income | 5.59M | 4.96M | 5.30M | 200.00K | null | |||
| Other Non-Current Liabilities | 75.42M | 57.77M | 54.51M | 0 | 400.00K | |||
| Total Non-Current Liabilities | 98.01M | 77.05M | 73.24M | 200.00K | 400.00K | |||
| TOTAL LIABILITIES | 105.47M | 84.33M | 82.82M | 3.30M | 14.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -407.55M | -376.47M | -319.64M | -288.30M | -236.60M | |||
| Additional Paid In Capital | 413.08M | 406.61M | 401.64M | 389.10M | 355.20M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 53.00K | 44.00K | 43.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 6.16M | -35.00K | 3.05M | -300.00K | -100.00K | |||
| Shares Outstanding | 53.62M | 44.00M | 42.97M | 36.10M | 30.10M | |||
| Tangible Book Value per Share | -1.0411 | -0.6795 | 0.0881 | 2.6233 | 3.9402 | |||
| Total Shareholders' Equity | 11.74M | 30.15M | 85.08M | 100.60M | 118.60M | |||
| TOTAL LIABILITIES AND EQUITY | 117.21M | 114.48M | 167.90M | 103.90M | 133.20M | |||
| Statistics | ||||||||
| Debt/Equity | 1.45 | 0.48 | 0.16 | N/A | N/A | |||
| Current Ratio | 5.00 | 6.05 | 8.09 | 30.23 | 7.87 | |||
| Return On Assets (ROA) | -41.83% | -49.64% | -18.69% | -49.72% | -67.53% | |||
| Return On Equity (ROE) | -417.77% | -188.51% | -36.89% | -51.35% | -75.84% | |||
All data in USD , ROIC based on taxRate of 0.21